Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-05-05
1989-02-14
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514218, 514390, 514397, 514399, 514400, 540575, 540603, 544370, 546276, 548336, 548346, A61K 31495, A61K 31415, C07D40310
Patent
active
048046620
ABSTRACT:
Novel substituted 4-[1H-imidazol-1-yl]benzamides and their use in the treatment of cardiac arrthythmias especially as Class III or combination Class I/III antiarrhythmic agents is described. Pharmaceutical formulations containing such compounds are also disclosed.
REFERENCES:
Inagaki et al., Image-Receiving Element for Silver Salt Diffusion.
Lis Randall E.
Lumma, Jr. William C.
Morgan, Jr. Thomas K.
Nickisch Klaus
Wohl Ronald A.
Bellamy Elizabeth A.
Daus Donald G.
Millen I. William
Schering A.G.
Shen Cecilia
LandOfFree
Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic age does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic age, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic age will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1365734